545 related articles for article (PubMed ID: 36385099)
1. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
2. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
Xiao L; Wang Q; Peng H
Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
[TBL] [Abstract][Full Text] [Related]
4. The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages.
Liang Y; He J; Chen X; Yin L; Yuan Q; Zeng Q; Zu X; Shen Y
Int J Biol Sci; 2023; 19(15):4915-4930. PubMed ID: 37781517
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
Qiao X; Hu Z; Xiong F; Yang Y; Peng C; Wang D; Li X
Lipids Health Dis; 2023 Mar; 22(1):45. PubMed ID: 37004014
[TBL] [Abstract][Full Text] [Related]
6. C1q
Zhang S; Peng W; Wang H; Xiang X; Ye L; Wei X; Wang Z; Xue Q; Chen L; Su Y; Zhou Q
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604643
[TBL] [Abstract][Full Text] [Related]
7. [A Review of the Lipid Metabolism Reprogramming in Tumor Associated Macrophages].
Zhao K; Shi RC; Miao HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):45-49. PubMed ID: 33474888
[TBL] [Abstract][Full Text] [Related]
8. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
[TBL] [Abstract][Full Text] [Related]
9. Metabolism in tumour-associated macrophages: a
Zheng X; Mansouri S; Krager A; Grimminger F; Seeger W; Pullamsetti SS; Wheelock CE; Savai R
Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004525
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
Tao H; Zhong X; Zeng A; Song L
Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
[TBL] [Abstract][Full Text] [Related]
11. Lipid Metabolic Regulatory Crosstalk Between Cancer Cells and Tumor-Associated Macrophages.
Liu S; Shen YY; Yin LY; Liu J; Zu X
DNA Cell Biol; 2023 Aug; 42(8):445-455. PubMed ID: 37535386
[TBL] [Abstract][Full Text] [Related]
12. Metabolism, metabolites, and macrophages in cancer.
Li M; Yang Y; Xiong L; Jiang P; Wang J; Li C
J Hematol Oncol; 2023 Jul; 16(1):80. PubMed ID: 37491279
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
[TBL] [Abstract][Full Text] [Related]
14. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
Li L; Ma SR; Yu ZL
Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
[TBL] [Abstract][Full Text] [Related]
15. Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.
Dubey S; Ghosh S; Goswami D; Ghatak D; De R
Biochem Pharmacol; 2023 Feb; 208():115369. PubMed ID: 36481347
[TBL] [Abstract][Full Text] [Related]
16. Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation.
Xiao B; Li G; Gulizeba H; Liu H; Sima X; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):442. PubMed ID: 38730286
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
18. Targeting tumor associated macrophages in hepatocellular carcinoma.
Xu W; Cheng Y; Guo Y; Yao W; Qian H
Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
[TBL] [Abstract][Full Text] [Related]
19. Macrophages and Metabolism in the Tumor Microenvironment.
Vitale I; Manic G; Coussens LM; Kroemer G; Galluzzi L
Cell Metab; 2019 Jul; 30(1):36-50. PubMed ID: 31269428
[TBL] [Abstract][Full Text] [Related]
20. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
Chen D; Zhang X; Li Z; Zhu B
Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]